tiprankstipranks
Trending News
More News >
Sionna Therapeutics, Inc. (SION)
:SION
US Market

Sionna Therapeutics, Inc. (SION) Financial Statements

Compare
4 Followers

Sionna Therapeutics, Inc. Financial Overview

Sionna Therapeutics, Inc.'s market cap is currently $561.26M. The company's EPS TTM is $; its P/E ratio is ―; Sionna Therapeutics, Inc. is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00
Gross Profit$ 0.00$ 0.00$ 0.00
Operating Income$ -70.56M$ -50.33M$ -41.37M
EBITDA$ -69.89M$ -49.75M$ -41.25M
Net Income$ -61.69M$ -47.26M$ -40.24M
Balance Sheet
Cash & Short-Term Investments$ 147.54M$ 38.52M$ 82.61M
Total Assets$ 185.75M$ 51.95M$ 87.37M
Total Debt$ 9.75M$ 10.48M$ 0.00
Net Debt$ -28.04M$ -28.04M$ -54.84M
Total Liabilities$ 349.46M$ 166.83M$ 157.29M
Stockholders' Equity$ -163.71M$ -114.88M$ -69.92M
Cash Flow
Free Cash Flow$ -52.81M$ -44.81M$ -37.94M
Operating Cash Flow$ -52.79M$ -43.70M$ -36.07M
Investing Cash Flow$ -126.91M$ 27.35M$ -29.26M
Financing Cash Flow$ 178.97M$ 31.00K$ 110.86M
Currency in USD

Sionna Therapeutics, Inc. Earnings and Revenue History

Sionna Therapeutics, Inc. Debt to Assets

Sionna Therapeutics, Inc. Cash Flow

Sionna Therapeutics, Inc. Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis